Tablets & Capsules — Ask an Expert: Modifying a Previously Approved Sustained-Release Formulation
Wayne Wiley, senior director of regulatory affairs at Recro, explains how to avoid additional clinical studies when modifying a previously approved sustained-release formulation. Read the article on CMC filing to meet FDA expectations under the SUPAC guidance for modified release oral solid dosage forms.